Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins
about
Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analoguesMultidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesMRP3, an organic anion transporter able to transport anti-cancer drugsExpression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiationMultidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsExpression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heartRenal drug transporters and their significance in drug-drug interactionspABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cellsTissue distribution and induction of human multidrug resistant protein 3Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine.Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expressionXenobiotic, bile acid, and cholesterol transporters: function and regulation.ATP-binding cassette efflux transporters in human placenta.The MRP family of drug efflux pumps.N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids.ABCC5 is required for cAMP-mediated hindgut invagination in sea urchin embryos.Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application.Role of efflux pumps and metabolising enzymes in drug delivery.CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.Active transport across the human placenta: impact on drug efficacy and toxicity.Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxel.LOSS of Mrp1 alters detoxification enzyme expression in a tissue- and hormonal-status-specific manner.Identification and bioinformatic characterization of a multidrug resistance associated protein (ABCC) gene in Plasmodium berghei.Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiologyHuman multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.Characterization of hepatic-organoid cultures.Role of multidrug transporters in neurotherapeuticsMultidrug resistance associated proteins in multidrug resistance.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3.MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver.Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate.Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer.Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
P2860
Q24533593-3C141EEA-A8C2-49E7-8E52-18FDF2747A87Q24601963-7CD32354-132E-45F1-9771-6BC29930E163Q24650550-624004D5-CF01-47B2-BC22-485EC7012171Q24675829-11ED8D6F-6B3C-4BAC-9EF8-E62951159A61Q24681283-FB01384C-54BE-4933-95EC-627153482192Q24685159-E295A530-40CA-4332-8850-CBA7C8F96D1FQ28071292-65C8EB51-C857-4508-973D-E388E19081B3Q28141486-D4F637BE-B655-4FD8-9B93-FB69BEDDF20AQ28201985-FE2A49E4-A9BD-4C6A-895F-DB33B01F3301Q33183493-BF87942E-0517-4003-AEB7-FC7681394406Q33285545-CD47FF24-66E6-44CF-9745-12A64EBC9AC6Q33714593-7C70263E-4C50-4BE8-B2ED-8AA551DF3178Q34843023-DBCB6E3A-6CDE-4AE8-B076-A418E695AC92Q35567296-E5DD9DBC-99C6-4797-88EB-40C6BA273D78Q35669404-BB8C10AC-9B88-4A55-B36A-2525D1EC80A7Q36245109-39FE194A-1355-432D-B869-DD89EE807FDBQ36271954-EBF969E7-CEAF-44CE-914C-715772E5DE9FQ36316872-0CAD8BCB-2291-4BAF-AE64-1065321477D8Q36367680-5EE3DE51-5FB9-4F4A-8E82-110CB5AA14BCQ36381928-939C4427-76CC-4C35-B31C-23163625630EQ36525551-113A683E-F7B4-48AC-B1FE-EF57341A22E1Q36545029-72AA447C-4B36-4362-9864-0109EE2E6A65Q36885663-82B599CC-C84D-43F7-83CB-A420A3B943F0Q37058949-E4CBB4B3-8C4D-486D-9DB3-83A2EE339BF1Q37073015-08695C1D-CB17-41D9-B224-8F06D420F265Q37218229-71CD800C-54AB-4484-A69F-098EA170962EQ37266833-DC3F3AEC-3FD5-4F26-8D11-835D4DA04897Q37351193-A3EE8CBA-A7CC-4755-97F6-7B000044352DQ37660405-38EA2225-E60D-436E-818A-6470FF677EFDQ37689499-3F887307-C97F-401A-8D34-0975E1737B83Q37958163-28E239B8-9288-4DDA-9C27-76DE249DE4A3Q38266172-93B9585A-2D4B-4F85-B26C-AB4F8127E29FQ38958745-65910393-FE10-4E1F-B356-4B57C4F76ECDQ40397699-2BEA52E9-6D7A-430F-A12E-08F4DBE475DFQ40696242-1E504F67-C19D-46DD-99BD-7A5C55531EA5Q42053609-7B80A2F9-1D67-4F63-AE36-C8CC4BDA333AQ43009114-B27754AA-C5F3-4CAB-8490-FF68F5373598Q43579978-109C6BA7-74AB-4FC2-9EC4-F050E47A60CDQ43690852-123B01CA-BB2E-4327-BFCF-38122445869FQ43824423-F1DE6415-64D8-47E7-9635-38F91F62D0EF
P2860
Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of MOAT-C and ...... family of transporter proteins
@ast
Characterization of MOAT-C and ...... family of transporter proteins
@en
Characterization of MOAT-C and ...... family of transporter proteins
@en-gb
Characterization of MOAT-C and ...... family of transporter proteins
@nl
type
label
Characterization of MOAT-C and ...... family of transporter proteins
@ast
Characterization of MOAT-C and ...... family of transporter proteins
@en
Characterization of MOAT-C and ...... family of transporter proteins
@en-gb
Characterization of MOAT-C and ...... family of transporter proteins
@nl
prefLabel
Characterization of MOAT-C and ...... family of transporter proteins
@ast
Characterization of MOAT-C and ...... family of transporter proteins
@en
Characterization of MOAT-C and ...... family of transporter proteins
@en-gb
Characterization of MOAT-C and ...... family of transporter proteins
@nl
P2093
P2860
P3181
P356
P1476
Characterization of MOAT-C and ...... family of transporter proteins
@en
P2093
P2860
P304
P3181
P356
10.1093/JNCI/90.22.1735
P407
P577
1998-11-18T00:00:00Z